Clearance of Erythroderma in a Patient on Apremilast and Positive Patch Test Reactions While on Treatment

Abstract

Get full access to this article

View all access options for this article.

References

Fowler

Jr , Maibach

, Zirwas

, et al. Effects of immunomodulatory agents on patch testing: expert opinion 2012. Dermatitis, 2012; 23:301–.

Moustafa

, Feldman

. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase-4 inhibitors in clinical dermatology. Dermatol Online J, 2014; 20:22608.

Baumer

, Hoppmann

, Runfeldt

, et al. Highly selective phosphodiesterase 4 inhibitors for the treatement of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets, 2007; 6:17–26.

Schafer

. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol, 2012; 83:1583–1590.

Schafer

, Day

. Novel systemic drugs for psoriasis: mechanism of action for apremilast, a specific inhibitor of PDE-4. J Am Acad Dermatol, 2013; 68:1041–1042.